DermaSensor

Name: DermaSensor
Address: Miami, FL, 33130, US
Telephone: +18553736767

Call Directions Website Contact the business

America’s first FDA-cleared, AI-powered skin cancer detection device. Clinically proven and trusted by Primary Care Physicians.

DermaSensor is designing an affordable handheld sensor that will be able to evaluate skin for potential cancer in seconds. Results will be displayed instantly. Our device will use machine learning algorithms, a type of artificial intelligence, to more accurately assess potential skin cancer.

10/16/2026

We’re heading to AAFP FMX 2026! 🎉

📍 Nashville, TN | October 21–23 | Booth #2540

Stop by our booth to explore our innovative skin cancer risk detection technology and see it in action with a complimentary live demo!

We look forward to connecting with you in Nashville!

10/05/2026

After more than 30 years in practice, Dr. Brad Rodgers sees DermaSensor changing the way he approaches skin concerns in primary care.

A board-certified family physician, Dr. Rodgers describes DermaSensor as a “new vital sign” in his practice, giving him a new way to evaluate patients’ concerning skin lesions.

Hear directly from Dr. Rodgers about how DermaSensor has changed his approach to skin cancer risk detection.

Learn more at https://www.dermasensor.com/

10/01/2026

50,083 lesions scanned. And counting.

Today, DermaSensor reached an important milestone: more than 50,000 suspicious skin lesions have now been scanned using our technology.

Based on the prevalence of skin cancer observed among suspicious lesions in the DERM-SUCCESS FDA pivotal study, an estimated 7,512 of those lesions represent skin cancers.*

Behind every scan is a patient. A clinical decision. And an opportunity to identify risk when it matters.

We built DermaSensor to give clinicians an objective, non-invasive tool to immediately assess suspicious skin lesions at the point of care.

50,083 lesions scanned.
7,512 estimated skin cancers.
And we’re just getting started.

*Estimate based on the prevalence of skin cancer among suspicious lesions in the DERM-SUCCESS FDA pivotal study.

09/29/2026

The only FDA-cleared automated solution for skin cancer detection and it fits in the palm of your hand.

DermaSensor combines AI-driven technology with Elastic Scattering Spectroscopy to help physicians evaluate lesions suggestive of melanoma, basal cell carcinoma, and squamous cell carcinoma, delivering an objective result at the point of care.

Designed for real clinical settings where time is limited and decisions matter.

Ready to bring objective skin cancer risk assessment into your practice? Request a demo at the link in bio.

09/23/2026

Skin cancer is one of the most common types of cancer, and early detection can make a major difference in outcomes.

For primary care providers, routine visits can be an important opportunity to identify suspicious lesions and take action sooner.

DermaSensor brings objective, AI-powered skin cancer risk assessment to the point of care to help support confident next-step decisions.

Ready to strengthen skin cancer detection in your practice? Visit the link in bio to learn more or request a demo.

09/22/2026

Before schedules fill up, get your annual physicals, screenings, and skin checks on the calendar.

A little planning now can make it easier to stay on top of preventive care before the holiday rush.

Need a provider? Use the DermaSensor Physician Finder at the link in bio to find a physician near you and schedule your skin check.

09/18/2026

Summer may be winding down, but the effects of sun exposure can stay with us.
As fall wellness visits and annual physicals pick up, it’s a timely opportunity to make skin checks part of comprehensive care, especially when a suspicious lesion comes up during a routine exam.

DermaSensor is built for clinical settings, combining elastic scattering spectroscopy technology with artificial intelligence to support clinicians with an immediate result at the point of care.

Make skin health part of the conversation this fall.
Learn more about DermaSensor at dermasensor.com

09/17/2026

Primary care is often where suspicious skin lesions are first noticed and where important referral decisions begin.

DermaSensor brings objective, real-time information into the exam room to support clinical decision-making when it matters most.

See how DermaSensor can help strengthen skin cancer risk assessment in your practice. Visit the link in bio to learn more.

09/16/2026

More practices are making room for DermaSensor and the clinical value speaks for itself.

With 96% sensitivity, FDA clearance, non-invasive technology, and immediate results, DermaSensor gives clinicians objective information to support skin cancer risk assessment right at the point of care.

Built for real clinical settings. Designed to support confident decisions without slowing down the visit.

See how DermaSensor can fit into your practice. Visit the link in bio to learn more

09/15/2026

Summer may be winding down, but UV damage doesn’t disappear with the season. ☀️

Sun exposure adds up over time, and repeated sunburns can significantly increase the risk of skin cancer, including melanoma.

Keep paying attention to your skin year-round, especially any spots that are new, changing, or concerning.

If a suspicious lesion raises a question, DermaSensor gives clinicians an AI-powered, non-invasive tool to support skin cancer risk assessment in real time.

Find a DermaSensor provider near you or learn more at the link in bio.

Address

Miami, FL
33130

Telephone

+18553736767

Website

https://www.dermasensor.com/

Alerts

Be the first to know and let us send you an email when DermaSensor posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to DermaSensor:

Want your business to be the top-listed engineering company in Miami?